"Valuind EQ-5D using Time Trade-Off in France" (G. De Pouvourville, J. Chevalier), of Health Economics
  "Characteristics, treatment, and outcome of breast cancers diagnosed in BRCA1 and BRCA2 gene mutation carriers in intensive screening programs including magnetic resonance imaging" (E. Chéreau, C. Uzan, C. Balleyguier, J. Chevalier, J. Chevalier, B. Bressac‑De‑Paillerets, O. Caron, F. Rimareix, M. Mathieu, M. Koskas, C. Bourgier, F. André, C. Dromain), Clinical Breast Cancer, Apr 2010, Vol. 10, Issue 2, p. 113‑118
  "Peritoneal carcinomatosis of colorectal origin : systematic chemotherapy versus complete cytoreduective surgery plus intraperitoneal chemohyperthermia with oxaliplatin. A comparative study of patients with similar disease and 8 years of follow-up." (D. Elias, J. Lefevre, J. Chevalier, Et Al.), Journal of Clinical Oncology, Feb 2009, Vol. 27, Issue 5, p. 681‑685
  "Cost-effectiveness of intraperitoneal chemohyperthermia in the treatment of peritoneal carcinomatosis from colorectal cancer" (J. Bonastre, J. Chevalier, Et Al.), Value In Health, May 2008, Vol. 11, Issue 3, p. 347‑353
  "Radioiodine ablation in thyroid cancer patients: comparison of length and cost of hospital stay between preparation by thyroid hormone withdrawal and thyrogen" (I. Borget, H. Rémy, J. Chevalier, Et Al.), Eur j Nucl Med Mol Imaging, Apr 2008, Vol. 2
  "The economic burden of melanoma in France: assessing health care use in a hospital setting" (J. Chevalier, J. Bonastre, M. Avril), Melanoma Research, Feb 2008, Vol. 18, Issue 1, p. 40‑46
  " Learning effects and hospital costs in innovative health technologies in a Prospective Payment System? " (J. Chevalier, J. Bonastre, E. Noel, Et Al.), International Journal of Technology Assessment in Health Care, Apr 2007, Vol. 23, Issue 2, p. 248‑254